Emerging Markets (EMs) are delivering standout value and returns. With 17.0% net gains to end July, EMs have outperformed Developed Markets (DMs), which lagged at 13.1%. Yet, despite this outperformance, EMs remain deeply undervalued: at 14x forward price-to-earnings, they are 30% cheaper than DMs and a striking 42% cheaper than the US. Add in the low price-to-book ratios and higher dividend yields versus the US, and the case for EMs becomes more compelling.

Read Eastspring’s Deep Dive into Emerging Markets